Figure 9.
Relationship between risk groups and immune subtypes. (A) Patients in the TCGA cohort were divided into three immune subtypes based on the immune infiltrating landscape. (B) The distribution of three immune subtypes between the two risk groups. (C, D) Validation of the immune subtypes and their distribution in GSE20711. (E, F) Association of risk scores of immune subtypes with response to immunotherapy.
